Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENZALUTAMIDE vs EPINEPHRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENZALUTAMIDE vs EPINEPHRINE: Safety Overview

Metric ENZALUTAMIDE EPINEPHRINE
Total FAERS Reports 49,270 15,112
Deaths Reported 9,676 1,469
Death Rate 19.6% 9.7%
Hospitalizations 9,282 4,388
Average Patient Age 76.0 yrs 43.5 yrs
% Female Patients 0.6% 58.7%
FDA Approval Date Apr 22, 2022 Approved Prior to Jan 1, 1982
Manufacturer Astellas Pharma US, Inc. Henry Schein, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued